Literature DB >> 1341939

Appraising the use of contingent valuation.

G C Morrison1, M Gyldmark.   

Abstract

The valuation of treatments and health states has been pursued in a number of ways. Most predominant are contingent valuation (CV), QALYs, and HYEs. CV--that is, willingness to pay and willingness to accept--is the only one of these methods that can be consistent with welfare economic theory, but, as discussed by Gafni (1990), in order to do so three criteria must be met. This article argues that the fulfilment of these criteria is not sufficient to obtain useful results, and some additional criteria are suggested. Several CV studies carried out in the area of health are reviewed, and their compliance or non-compliance, with both sets of criteria, is discussed. Finally, it is argued that, although CV is the more theoretically correct method, it is not a superior tool to QALYs and HYEs, and that the decision as to which is the appropriate valuation method depends on the policy issue at hand.

Mesh:

Year:  1992        PMID: 1341939     DOI: 10.1002/hec.4730010405

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  10 in total

1.  Estimating rural households' willingness to pay for health insurance.

Authors:  Ali Asgary; Ken Willis; Ali Akbar Taghvaei; Mojtaba Rafeian
Journal:  Eur J Health Econ       Date:  2004-10

2.  Assessing willingness to pay for improved sanitation in rural Vietnam.

Authors:  Hoang Van Minh; Hung Nguyen-Viet; Nguyen Hoang Thanh; Jui-Chen Yang
Journal:  Environ Health Prev Med       Date:  2012-11-10       Impact factor: 3.674

3.  Conjoint analysis of a new Chemotherapy: willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced Colorectal Cancer.

Authors:  Mike Aristides; Jack Chen; Mark Schulz; Eve Williamson; Stephen Clarke; Kaye Grant
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 4.  The impact of economic evaluation on quality management in spine surgery.

Authors:  Norbert Boos
Journal:  Eur Spine J       Date:  2009-04-01       Impact factor: 3.134

5.  Cost-benefit analysis.

Authors:  R Robinson
Journal:  BMJ       Date:  1993-10-09

6.  Increasing access to modern contraceptives: the potential role of community solidarity through altruistic contributions.

Authors:  Obinna E Onwujekwe; Chinwe Ogbonna; Nkoli Uguru; Benjamin S C Uzochukwu; Agathe Lawson; Bannet Ndyanabangi
Journal:  Int J Equity Health       Date:  2012-07-06

7.  Socio-economic inequity in demand for insecticide-treated nets, in-door residual house spraying, larviciding and fogging in Sudan.

Authors:  Obinna Onwujekwe; El-Fatih Mohamed Malik; Sara Hassan Mustafa; Abraham Mnzava
Journal:  Malar J       Date:  2005-12-15       Impact factor: 2.979

8.  Willingness to pay for antiretroviral drugs among HIV and AIDS clients in south-east Nigeria.

Authors:  Chinyere Mbachu; Chijioke Okoli; Obinna Onwujekwe; Fabian Enabulele
Journal:  Health Expect       Date:  2017-08-14       Impact factor: 3.377

9.  Quantifying the economic burden of malaria in Nigeria using the willingness to pay approach.

Authors:  Ayodele Jimoh; Oluyemi Sofola; Amos Petu; Tuoyo Okorosobo
Journal:  Cost Eff Resour Alloc       Date:  2007-05-22

10.  Indirect cost of maternal deaths in the WHO African Region in 2010.

Authors:  Joses Muthuri Kirigia; Germano Mwige Mwabu; Juliet Nabyonga Orem; Rosenabi Deborah Karimi Muthuri
Journal:  BMC Pregnancy Childbirth       Date:  2014-08-31       Impact factor: 3.007

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.